In addition, there is concern over increasing rates of disease recurrence (including relapse and reinfection) after anti-TB drug therapy and an increasing trend of multidrug- and extensively drug-resistant (M/XDR) TB worldwide.
← all excerpts
Urine IP-10 as a biomarker of therapeutic response in patients with active pulmonary tuberculosis.
1
—
—